Enforcement Report - Week of May 15, 2024
Health Canada Issues Recall of Dr. Reddy`s Sapropterin
Health Canada Issues Recall of Dr. Reddy`s Lab Canada`s Sapropterin
Dr. Reddy's Laboratories Ltd on Tuesday announced that it is voluntarily recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg in the U.S. due to powder discoloration in some packets, leading to decreased potency
Dr. Reddy’s Issues Voluntary Nationwide Recall of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg Due to Sub-Potency
Dipharma`s Sapropterin Receives Approval in the Europe
Annora's Generic Sapropterin Dihydrochloride Disodium Receives Approval in the U.S.
Dr. Reddy`s Generic Sapropterin dihydrochloride Receives Approval in the U.S.
Dipharma B.V.'s Generic Sapropterin Hydrochloride Receives Approval in Europe
Enforcement Report - Week of March 02, 2022